| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-05 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |